Weighted Average Number of Shares Outstanding, Basic of CNBX Pharmaceuticals Inc. from 28 Feb 2021 to 30 Nov 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
CNBX Pharmaceuticals Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 28 Feb 2021 to 30 Nov 2025.
  • CNBX Pharmaceuticals Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Nov 2025 was 732,857,211, a 2256% increase year-over-year.
  • CNBX Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 90,649,474, a 200% increase from 2024.
  • CNBX Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 30,247,691, a 243% increase from 2023.
  • CNBX Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 8,824,636, a 622% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

CNBX Pharmaceuticals Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 732,857,211 +701,745,859 +2256% 01 Sep 2025 30 Nov 2025 10-Q 14 Jan 2026 2026 Q1
Q3 2025 90,649,474 +60,401,783 +200% 01 Jun 2025 31 Aug 2025 10-K 01 Dec 2025 2025 FY
Q2 2025 42,597,394 +11,486,042 +37% 01 Mar 2025 31 May 2025 10-Q 14 Jul 2025 2025 Q3
Q1 2025 32,096,769 +1,108,494 +3.6% 01 Dec 2024 28 Feb 2025 10-Q 14 Apr 2025 2025 Q2
Q4 2024 31,111,352 +3,350,550 +12% 01 Sep 2024 30 Nov 2024 10-Q 14 Jan 2026 2026 Q1
Q3 2024 30,247,691 +21,423,055 +243% 01 Jun 2024 31 Aug 2024 10-K 01 Dec 2025 2025 FY
Q2 2024 31,111,352 +21,845,487 +236% 01 Mar 2024 31 May 2024 10-Q 14 Jul 2025 2025 Q3
Q1 2024 30,988,275 +29,025,276 +1479% 01 Dec 2023 29 Feb 2024 10-Q 14 Apr 2025 2025 Q2
Q4 2023 27,760,802 +26,502,875 +2107% 01 Sep 2023 30 Nov 2023 10-Q 13 Jan 2025 2025 Q1
Q3 2023 8,824,636 +7,601,995 +622% 01 Jun 2023 31 Aug 2023 10-K 29 Nov 2024 2024 FY
Q2 2023 9,265,865 +8,027,039 +648% 01 Mar 2023 31 May 2023 10-Q 15 Jul 2024 2025 Q3
Q1 2023 1,962,999 +736,814 +60% 01 Dec 2022 28 Feb 2023 10-Q 16 Apr 2024 2024 Q2
Q4 2022 1,257,927 -129,847,912 -99% 01 Sep 2022 30 Nov 2022 10-Q 12 Jan 2024 2024 Q1
Q3 2022 1,222,641 01 Jun 2022 31 Aug 2022 10-K 30 Nov 2023 2023 FY
Q2 2022 1,238,826 +106,354 +9.4% 01 Mar 2022 31 May 2022 10-Q 14 Jul 2023 2023 Q3
Q1 2022 1,226,185 -134,011,399 -99% 01 Dec 2021 28 Feb 2022 10-Q 14 Apr 2023 2023 Q2
Q4 2021 131,105,839 01 Sep 2021 30 Nov 2021 10-Q 13 Jan 2023 2023 Q1
Q2 2021 1,132,472 01 Mar 2021 31 May 2021 10-Q 14 Jul 2022 2022 Q3
Q1 2021 135,237,584 01 Dec 2020 28 Feb 2021 10-Q 12 Apr 2022 2022 Q2

CNBX Pharmaceuticals Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 90,649,474 +60,401,783 +200% 01 Sep 2024 31 Aug 2025 10-K 01 Dec 2025 2025 FY
2024 30,247,691 +21,423,055 +243% 01 Sep 2023 31 Aug 2024 10-K 01 Dec 2025 2025 FY
2023 8,824,636 +7,601,995 +622% 01 Sep 2022 31 Aug 2023 10-K 29 Nov 2024 2024 FY
2022 1,222,641 -137,296,868 -99% 01 Sep 2021 31 Aug 2022 10-K 30 Nov 2023 2023 FY
2021 138,519,509 01 Sep 2020 31 Aug 2021 10-K 30 Nov 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.